Ventricular tachycardia substrate mapping with cardiac computed tomography and cardiac magnetic resonance imaging: Head-to-head comparison of two clinically available postprocessing platforms.

Damian Laan¹, Luuk H G A Hopman¹, Rosa M Figueras I Ventura², Bruno Soré³, Cornelis P Allaart¹, Michiel J B Kemme¹, Marco J W Götte¹, Pieter G Postema¹, Pranav Bhagirath⁴

¹Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.

²Adas3D Medical S.L., Barcelona, Spain.

³inHEART SAS, Pessac, France.

⁴Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands; School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom. Electronic address: p.bhagirath@amsterdamumc.nl.

PubMed DOI

Abstract

BACKGROUND: Advanced postprocessing of late gadolinium enhancement cardiac magnetic resonance (CMR) and computed tomography (CCT) imaging increasingly guides ventricular tachycardia ablation. However, a direct comparison between 2 widely adopted platforms, ADAS 3D LV (Adas3D Medical) and inHEART (IHU Liryc/Inria), is lacking. OBJECTIVE: This study aimed to compare CMR- and CCT-derived ventricular…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.